Lead partner: The year the United Kingdom becomes a globally leading life sciences hub? Guest Blog As part of its ambition for the United Kingdom to become a tech and science superpower by 2030, in 2023,…
‘You’d be a brave innovator to ignore the UK’ – why patent work is booming in the post-Brexit UK life sciences market Marie Johansen Nordland Buzz about blockbuster drug developments, expiring patents and the launch of the European Union’s Unified Patent Court – 2023 certainly…
Taking back control – the post-pandemic landscape for life sciences regulation Sophie Chan After years of delays caused by geopolitical instability and the Covid-19 pandemic, the new regulatory landscape for the life sciences…
The Legal 500 view: Healthy competition Ben Wheway The Legal 500’s life science and healthcare industry focus ranking was introduced three years ago to recognise firms with dedicated…
Sponsored thought leadership: Healthcare and pharmaceutical regulation in Portugal Guest Blog The health sector in Portugal, which encompasses the pharmaceutical market, is a prominent and fast-evolving sector that has undergone significant…
